MIRA
INFORM REPORT
|
Report Date : |
03.07.2008 |
IDENTIFICATION
DETAILS
|
Name : |
SABAA INTERNATIONAL CO FOR PHARMACEUTICALS & CHEMICALS |
|
|
|
|
Registered Office : |
Villa Al Maden Koliet
Al Banat, 6 Ahmed Shaker Street, Heliopolis, PO Box 413, Cairo |
|
|
|
|
Country : |
Egypt |
|
|
|
|
Date of Incorporation : |
2000 |
|
|
|
|
Legal Form : |
Egyptian Joint Stock Company |
|
|
|
|
Line of Business : |
Manufacture of Pharmaceuticals |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$ 150,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
SUMMARY
Company Name : SABAA INTERNATIONAL CO FOR PHARMACEUTICALS & CHEMICALS
INDUSTRIES
Country of Origin : Egypt
Legal Form : Egyptian Joint Stock Company
Registration Date : 2000
Authorised Capital : £E 50,000,000
Issued Capital : £E 25,000,000
Paid up Capital : £E 25,000,000
Total Workforce : 35
Activities : Manufacture of pharmaceuticals
Financial Condition : Undetermined
Payments : Nothing detrimental uncovered
Recommended Credit Limit : US$ 150,000
COMPANY NAME
SABAA INTERNATIONAL
CO FOR PHARMACEUTICALS & CHEMICALS INDUSTRIES
ADDRESS
Registered & Physical Address
Building : Villa Al Maden Koliet Al Banat
Street : 6 Ahmed Shaker Street
Area : Heliopolis
PO Box : 413
Town : Cairo
Country : Egypt
Telephone : (20-2) 24148529
Facsimile : (20-2) 22918390 / 24147619
Premises
Subject operates from
a medium sized suite of offices that are rented and located in the Central
Business Area of Cairo.
Branch Office (s)
Location Description
·
Baltiem
Industrial Zone Factory
premises
Dessouk
Kafr El Sheikh
KEY PRINCIPALS
Name Position
·
El
Sayed Abd El Nabi Mohamed El Beilly Chairman
·
Sahl
Morsi Mohamed Morsi El Damrawy Managing
Director
LEGAL FORM & OWNERS
Date of Establishment : 2000
Legal Form :
Egyptian Joint Stock
Company
Authorised
Capital : £E 50,000,000
Issued Capital : £E 25,000,000
Paid up Capital : £E 25,000,000
Name of Shareholder (s)
·
El
Sayed Abd El Nabi Mohamed El Beilly
·
Sahl
Morsi Mohamed Morsi El Damrawy
·
Ali
Aouf
·
Abeer
Ezzat Zahran
OPERATIONS
Activities: Engaged in the manufacture of pharmaceuticals.
Import
Countries: Italy, Austria
and India
Subject has a
workforce of 35 employees.
FINANCIAL DATA
Companies
registered in Egypt are not legally required to make their accounts public and
no financial information was released by the company or submitted by outside
sources.
BANKERS
·
Banque du
Caire SAE
19
Adly Street
Cairo
Tel: (20-2)
3926915
Fax: (20-2)
3951713
PAYMENT HISTORY
No complaints
regarding subject’s payments have been reported.
GENERAL COMMENTS
During the course
of this investigation nothing detrimental was uncovered regarding subject’s
operating history or the manner in which payments are fulfilled. As such the
company is considered to be a fair trade risk.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.43.21 |
|
UK Pound |
1 |
Rs.85.72 |
|
Euro |
1 |
Rs.67.92 |
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)